PTPN11 and breast cancer: To further confirm that Cyclin D1 degradation induced by SHP2 loss occurred through the ubiquitin–proteasome pathway, we determined whether the deletion of SHP2 increased ubiquitinated Cyclin D1 in breast cancer cells.